髄膜炎菌ワクチン市場レポート：2023-2033
Meningococcal Vaccines Market Report 2023-2033
レポート詳細
髄膜炎菌ワクチン市場レポート 2023-2033 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なも... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
髄膜炎菌ワクチン市場レポート 2023-2033:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。
髄膜炎の有病率の増加が市場成長を促進
髄膜炎菌ワクチンの採用が進んでいること、先進国および発展途上国において髄膜炎やその他のウイルス性疾患の有病率が上昇していることが、市場成長の原動力になると予測されています。また、研究開発への投資の増加や、ウイルス性疾患の治療のための新薬の上市も、市場の成長をさらに後押ししています。米国、日本、欧州などの先進地域が市場で大きなシェアを占めているのは、先進国では発展途上国に比べて医療インフラが整備され、医療に対する意識が高いためです。したがって、これらの地域では、より高度で効率的な医薬品に対する需要が高いのです。一方、中国、インド、南アフリカなどの新興国市場は、政府の取り組み、呼吸器疾患に対する意識の高まり、可処分所得の増加などにより、高いペースで成長しています。
マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか？
- 髄膜炎菌ワクチン市場はどのように進化しているのか？
- 何が髄膜炎菌ワクチン市場を促進し、抑制しているのでしょうか？
- 各髄膜炎菌ワクチンサブマーケットセグメントは予測期間中にどのように成長し、2033年にこれらのサブマーケットが占める収益はどの程度になるのでしょうか？
- 2023年から2033年にかけて、各髄膜炎菌ワクチンサブマーケットの市場シェアはどのように推移するのでしょうか？
- 2023年から2033年にかけて、市場全体の主な牽引役は何でしょうか？
- 主要な髄膜炎菌ワクチン市場はマクロ経済力学に広く追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、どの地域が2033年に市場をリードするのでしょうか？
- 主要プレイヤーは誰で、予測期間中の見通しはどうですか？
- これらの主要企業の髄膜炎菌ワクチンプロジェクトはどのようなものですか？
- 2023年から2033年の間に、業界はどのように進化するのでしょうか？また
現在および今後10年間に実施される髄膜炎菌ワクチンプロジェクトの意味は何ですか？
- 髄膜炎菌ワクチン市場をさらに拡大するために、製品の商業化の必要性が高まっているのでしょうか？
- 髄膜炎菌ワクチン市場はどこへ向かっており、どのようにすれば市場の最前線に立てるのでしょうか？
- 新製品やサービスラインに対する最適な投資オプションは何ですか？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？
このことが、現在および今後10年間の髄膜炎菌ワクチン市場にどのような影響を与えるかを見極める必要があります。
- 214ページにわたる本レポートでは、83の表と132のグラフを独占的に提供します。
- このレポートでは、業界における主要な収益性の高い分野に焦点を当て、お客様が今すぐターゲットとできるような情報を提供しています。
- 世界、地域、国別の売上高と成長率を詳細に分析しています。
- 競合他社が成功した主なトレンド、変化、収益予測をハイライトしています。
本レポートは、髄膜炎菌ワクチン市場が今後10年間にどのように発展するか、またCOVID-19の景気後退と回復の変動に伴ってどのように発展するかを今日あなたに伝えます。この市場は、過去10年間のどの時点よりも今が重要なのです。
2033年までの予測やその他の分析により、商業的な展望が見えてきた
- 2033年までの収益予測に加え、直近の実績、成長率、市場シェアもご覧いただけます。
- ビジネスの展望や展開など、独自の分析もご覧いただけます。
- 定性的分析（市場力学、ドライバー、機会、阻害要因など）、ポーターの5つの力分析、PEST分析、最近の動向などをご覧いただけます。
本レポートでは、COVID-19が業界と貴社にどのような影響を及ぼすかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。
報告書の対象セグメント
ワクチンタイプ
- 結合剤
- 多糖類
- その他
ワクチンブランド
- Bexsero
- Menactra
- Menveo
- その他
エンドユーザー
- 小児
- 成人
- 旅行者
世界市場全体とセグメントの収益予測に加え、5つの地域と21の主要国市場の収益予測も掲載しています。
北米
- アメリカ
- カナダ
欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- ロシア
- その他の欧州
アジア太平洋地域
- 日本
- 中国
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ地域
MEA
- GCC
- 南アフリカ
- その他のMEA地域
髄膜炎菌ワクチン市場の2023年から2033年までの主要企業のプロファイルと、これらの企業の事業のこのセグメントに焦点を当てたものも含まれています。
主要企業と市場成長の可能性
・ BIO-MED
・ GSK plc
・ Incepta Pharmaceuticals Ltd.
・ Merck ＆ Co., Inc.
・ Pfizer Inc.
・ Sanofi
・ Serum Institute of India Pvt. Ltd.
・ Walvax Biotechnology Co., Ltd.
・ Zhi Fei Biological
髄膜炎菌ワクチン市場の世界全体の収益、2023年から2033年まで金額ベースで、市場は2023年に34億4340万米ドルを突破すると、我々の仕事は計算されます。2033年まで力強い収益成長が予測されます。この調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。
髄膜炎菌ワクチン市場、2023年から2033年までのレポートはどのように役立つのでしょうか？
210ページを超えるレポートでは、要約すると以下のような知識を得ることができます。
- 髄膜炎菌ワクチン市場の2033年までの収益予測、ワクチンタイプ、ワクチンブランド、エンドユーザーの各予測を世界および地域レベルで掲載 - 業界の展望を見出し、投資と収益に最も有利な場所を見つけることができます。
- 5地域と21主要国市場の2033年までの収益予測 - 髄膜炎菌ワクチン市場、2023年から2033年までの北米、ヨーロッパ、アジア太平洋、ラテンアメリカ、MEAの市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、イギリス、イタリア、中国、インド、日本、オーストラリアなど、主要経済圏の市場も予測しています。
- 既存企業や市場参入を目指す企業の展望 - 髄膜炎菌ワクチン市場に関わる主要企業9社の企業プロファイルを含む、2023年から2033年までの展望。
定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の調査、分析、意思決定にどのように役立つかをご覧ください。Visiongainの調査は、髄膜炎菌ワクチン市場、2023年から2033年、市場をリードする企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。
ページTOPに戻る
目次
目次
1.レポートの概要
1.1 研究の目的
1.2 髄膜炎菌ワクチン市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問には以下が含まれます。
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 一次調査
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問（FAQ)
1.9 関連するVisiongainのレポート
1.10 Visiongainについて
2 エグゼクティブサマリー
3 市場の概要
3.1 主要な調査結果
3.2 マーケットダイナミクス
3.2.1 市場の推進要因
3.2.1.1 髄膜炎の有病率の増加
3.2.1.2 政府や規制当局によるイニシアチブの増加
3.2.1.3 研究プロジェクトに資金を提供する非営利団体の存在
3.2.1.4 ワクチン試用は予測期間中に商業化される見込み
3.2.2 市場抑制要因
3.2.2.1 低い生産率、高いコスト
3.2.2.2 高い医薬品開発コストが新規プレイヤーの参入を阻む
3.2.2.3 ワクチン製造の長いタイムラインがワクチン市場の成長を阻害する
3.2.3 市場機会
3.2.3.1 新たなビジネスチャンスをもたらすNIPsへの組み込みの増加
3.3 COVID-19影響度分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーの交渉力。中
3.4.2 バイヤーの交渉力：中
3.4.3 競争相手との競争力：高
3.4.4 新規参入の脅威：低
3.4.5 代替品の脅威:低
3.5 PEST分析
3.5.1 髄膜炎菌ワクチン市場に影響を与える政治的要因
3.5.2 髄膜炎菌ワクチン市場に影響を与える経済的要因
3.5.3 髄膜炎菌ワクチン市場に影響を与える社会的要因
3.5.4 髄膜炎菌ワクチン市場に影響を与える技術的要因
4 髄膜炎菌ワクチン市場分析：ワクチンタイプ別
4.1 主な調査結果
4.2 ワクチンの種類別セグメント市場魅力度指数
4.3 髄膜炎菌ワクチンのワクチンタイプ別市場規模の推定と予測
4.4 複合型
4.4.1 地域別市場予測、2023年〜2033年 (US$ Mn)
4.4.2 地域別市場シェア、2023年＆2033年(%)
4.5 多糖類
4.5.1 地域別市場予測、2023年～2033年 (US$ Mn)
4.5.2 地域別市場シェア、2023年＆2033年(%)
4.6 その他
4.6.1 地域別市場予測、2023年〜2033年 (US$ Mn)
4.6.2 地域別市場シェア、2023年＆2033年(%)
5 髄膜炎菌ワクチン市場分析：ワクチンブランド別
5.1 主な調査結果
5.2 ワクチンブランドセグメント市場魅力度指数
5.3 髄膜炎菌ワクチンのワクチンブランド別市場規模の推定と予測
5.4 Bexsero
5.4.1 地域別市場予測、2023年〜2033年 (US$ Mn)
5.4.2 地域別市場シェア、2023年＆2033年(%)
5.5 Menactra
5.5.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.5.2 地域別市場シェア、2023年＆2033年(%)
5.6 Menveo
5.6.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.6.2 地域別市場シェア、2023年＆2033年(%)
5.7 その他
5.7.1 地域別市場予測、2023年～2033年 (US$ Mn)
5.7.2 地域別市場シェア、2023年＆2033年(%)
6 髄膜炎菌ワクチン市場分析：エンドユーザー別
6.1 主な調査結果
6.2 エンドユーザー・セグメント市場魅力度指数
6.3 髄膜炎菌ワクチンのエンドユーザー別市場規模の推定と予測
6.4 小児
6.4.1 地域別市場予測、2023年〜2033年 (US$ Mn)
6.4.2 地域別市場シェア、2023年＆2033年(%)
6.5 成人
6.5.1 地域別市場予測、2023年〜2033年 (US$ Mn)
6.5.2 地域別市場シェア、2023年＆2033年(%)
6.6 旅行者
6.6.1 地域別市場予測、2023年～2033年 (US$ Mn)
6.6.2 地域別市場シェア、2023年＆2033年(%)
7 髄膜炎菌ワクチン市場分析：地域別
7.1 主な調査結果
7.2 地域別市場規模の推定と予測
8 北米の髄膜炎菌ワクチン市場分析
8.1 主な調査結果
8.2 北米髄膜炎菌ワクチン市場魅力度指数
8.3 国別市場規模、2023年、2028年＆2033年（US$ Mn）
8.4 国別市場規模推計・予測、2023年～2033年（US$ Mn）
8.5 ワクチンタイプ別市場規模推定・予測、2023年～2033年（US$ Mn）
8.6 ワクチンブランド別の市場規模推定・予測、2023年〜2033年 (US$ Mn)
8.7 エンドユーザー別市場規模推計・予測、2023年～2033年（US$ Mn)
8.8 米国髄膜炎菌ワクチン市場分析
8.9 カナダの髄膜炎菌ワクチン市場分析
9 欧州の髄膜炎菌ワクチン市場分析
9.1 主な調査結果
9.2 欧州髄膜炎菌ワクチン市場魅力度指数
9.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
9.4 国別市場規模推計・予測、2023年～2033年（US$ Mn)
9.5 ワクチンタイプ別市場規模推定・予測、2023年～2033年（US$ Mn）
9.6 ワクチンブランド別の市場規模推定・予測、2023年〜2033年 (US$ Mn)
9.7 エンドユーザー別市場規模推定・予測、2023年～2033年（US$ Mn)
9.8 ドイツの髄膜炎菌ワクチン市場分析
9.9 イギリスの髄膜炎菌ワクチン市場分析
9.10 フランスの髄膜炎菌ワクチン市場の分析
9.11 イタリアの髄膜炎菌ワクチン市場の分析
9.12 スペイン 髄膜炎菌ワクチン市場の分析
9.13 ロシア 髄膜炎菌ワクチン市場の分析
9.14 その他の欧州の髄膜炎菌ワクチン市場分析
10 アジア太平洋地域の髄膜炎菌ワクチン市場分析
10.1 主要な調査結果
10.2 アジア太平洋地域の髄膜炎菌ワクチン市場の魅力度指数
10.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
10.4 国別市場規模推計・予測、2023年〜2033年（US$ Mn）
10.5 ワクチンタイプ別市場規模推定・予測、2023年～2033年（US$ Mn）
10.6 ワクチンブランド別の市場規模推定・予測、2023年〜2033年 (US$ Mn)
10.7 エンドユーザー別市場規模推定・予測、2023年～2033年 (US＄Mn)
10.8 日本 髄膜炎菌ワクチン市場分析
10.9 中国 髄膜炎菌ワクチン市場分析
10.10 インドの髄膜炎菌ワクチン市場分析
10.11 オーストラリアの髄膜炎菌ワクチンの市場分析
10.12 韓国 髄膜炎菌ワクチンの市場分析
10.13 その他のアジア太平洋地域の髄膜炎菌ワクチン市場分析
11 ラテンアメリカの髄膜炎菌ワクチン市場分析
11.1 主な調査結果
11.2 ラテンアメリカの髄膜炎菌ワクチン市場魅力度指数
11.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
11.4 国別市場規模の推定と予測、2023年～2033年（US$ Mn）
11.5 ワクチンタイプ別市場規模推定・予測、2023年～2033年（US$ Mn）
11.6 ワクチンブランド別の市場規模推定・予測、2023年〜2033年 (US$ Mn)
11.7 エンドユーザー別市場規模推定・予測、2023年～2033年（US$ Mn)
11.8 ブラジル髄膜炎菌ワクチン市場分析
11.9 メキシコの髄膜炎菌ワクチン市場分析
11.10 その他のラテンアメリカ地域の髄膜炎菌ワクチン市場分析
12 MEAの髄膜炎菌ワクチン市場分析
12.1 主な調査結果
12.2 MEA髄膜炎菌ワクチン市場魅力度指数
12.3 国別市場規模、2023年、2028年＆2033年（US$ Mn)
12.4 国別市場規模推計・予測、2023年～2033年（US$ Mn）
12.5 ワクチンタイプ別市場規模推定・予測、2023年～2033年（US$ Mn）
12.6 ワクチンブランド別の市場規模推定・予測、2023年〜2033年 (US$ Mn)
12.7 エンドユーザー別市場規模推定・予測、2023年～2033年（US$ Mn)
12.8 GCC髄膜炎菌ワクチン市場分析
12.9 南アフリカの髄膜炎菌ワクチン市場分析
12.10 その他のMEAの髄膜炎菌ワクチン市場の分析
13 主要企業のプロフィール
13.1 パイプライン分析
13.2 Sanofi
13.2.1 会社概要
13.2.2 会社概要
13.2.3 財務分析
13.2.3.1 純収益、2015-2021年
13.2.3.2 研究開発費、2015年-2021年
13.2.3.3 売上総利益、2015年-2021年
13.2.3.4 地域別マーケットシェア、2021年
13.2.4 製品ベンチマーク
13.2.5 戦略的な展望
13.3 Merck & Co., Inc.
13.3.1 企業スナップショット
13.3.2 会社概要
13.3.3 財務分析
13.3.3.1 純収益、2015-2021年
13.3.3.2 研究開発費、2015年-2021年
13.3.3.3 売上総利益、2015年-2021年
13.3.3.4 地域別マーケットシェア、2021年
13.3.4 製品ベンチマーク
13.4 GSK plc
13.4.1 会社概要
13.4.2 会社概要
13.4.3 財務分析
13.4.3.1 純収益、2015-2021年
13.4.3.2 研究開発費、2015年-2021年
13.4.3.3 売上総利益、2015年-2021年
13.4.3.4 地域別マーケットシェア、2021年
13.4.4 製品ベンチマーク
13.4.5 戦略的な展望
13.5 Pfizer Inc.
13.5.1 企業スナップショット
13.5.2 会社概要
13.5.3 財務分析
13.5.3.1 純収益、2015-2021年
13.5.3.2 研究開発費、2015年-2021年
13.5.3.3 売上総利益、2015年-2021年
13.5.3.4 地域別マーケットシェア、2021年
13.5.4 製品ベンチマーク
13.5.5 戦略的な展望
13.6 Serum Institute of India Pvt.Ltd.
13.6.1 企業スナップショット
13.6.2 会社概要
13.6.3 製品ベンチマーク
13.7 Zhi Fei Biological
13.7.1 企業スナップショット
13.7.2 会社概要
13.7.3 ベンチマーキング
13.8 Incepta Pharmaceuticals Ltd.
13.8.1 企業スナップショット
13.8.2 会社概要
13.8.3 ベンチマーキング
13.9 Walvax Biotechnology Co.
13.9.1 企業スナップショット
13.9.2 会社概要
13.9.3 ベンチマーキング
13.10 バイオメッド
13.10.1 企業スナップショット
13.10.2 会社概要
13.10.3 ベンチマーキング
14 結論と提言
14.1 ヴィジョンゲインからの結論
14.2 市場関係者への提言
表の一覧
Table 1 Meningococcal Vaccines Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 7 Conjugate Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 8 Polysaccharide Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 9 Others Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 10 Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 11 Bexsero Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 12 Menactra Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 13 Menveo Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 15 Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 16 Pediatric Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 17 Adult Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 18 Travelers Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 19 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 20 North America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 21 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 22 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 23 North America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 24 U.S. Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 25 Canada Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 26 Europe Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 27 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 28 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 29 Europe Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 30 Germany Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 31 UK Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 32 France Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 33 Italy Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 34 Spain Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 35 Russia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 36 Rest of Europe Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 37 Overview of the Epidemiology and Prevention of IMD Across the Asia–Pacific Region
Table 38 Asia Pacific Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 39 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 40 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 41 Asia Pacific Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 42 Japan Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 43 China Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 44 India Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 45 Australia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 46 South Korea Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 47 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 48 Latin America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 49 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 50 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 51 Latin America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 52 Brazil Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 53 Mexico Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 54 Rest of Latin America Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 55 MEA Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 56 MEA Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 57 MEA Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 58 MEA Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 59 GCC Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 60 South Africa Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 61 Rest of MEA Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 62 Meningococcal Vaccine: Pipeline Analysis
Table 63 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 64 Sanofi: Product Benchmarking
Table 65 Sanofi: Strategic Outlook
Table 66 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 Merck & Co., Inc.: Product Benchmarking
Table 68 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 GSK plc: Product Benchmarking
Table 70 GSK plc: Strategic Outlook
Table 71 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Pfizer Inc.: Product Benchmarking
Table 73 Pfizer Inc.: Strategic Outlook
Table 74 Serum Institute of India Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Serum Institute of India Pvt. Ltd.: Product Benchmarking
Table 76 Zhi Fei Biological: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Zhi Fei Biological: Product Benchmarking
Table 78 Incepta Pharmaceuticals Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Incepta Pharmaceuticals Ltd.: Product Benchmarking
Table 80 Walvwax Biotechnology Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Walvax Biotechnology Co., Ltd.: Product Benchmarking
Table 82 BIO-MED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 BIO-MED: Product Benchmarking
図の一覧
Figure 1 Meningococcal Vaccines Market Segmentation
Figure 2 Meningococcal Vaccines Market by Vaccine Type: Market Attractiveness Index
Figure 3 Meningococcal Vaccines Market by End-users: Market Attractiveness Index
Figure 4 Meningococcal Vaccines Market Attractiveness Index by Region
Figure 5 Meningococcal Vaccines Market: Market Dynamics
Figure 6 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 7 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 8 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 9 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 10 Meningococcal Vaccines Market: Porter’s Five Forces Analysis
Figure 11 Meningococcal Vaccines Market: PEST Analysis
Figure 12 Meningococcal Vaccines Market Attractiveness Index by Vaccine Type
Figure 13 Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 14 Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023, 2028, 2033 (%)
Figure 15 Conjugate Market Forecast by Region, 2023-2033 (US$ million)
Figure 16 Conjugate Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Polysaccharide Market Forecast by Region, 2023-2033 (US$ million)
Figure 18 Polysaccharide Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 20 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Meningococcal Vaccines Market Attractiveness Index by Vaccine Type
Figure 22 Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 23 Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023, 2028, 2033 (%)
Figure 24 Bexsero Market Forecast by Region, 2023-2033 (US$ million)
Figure 25 Bexsero Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Menactra Market Forecast by Region, 2023-2033 (US$ million)
Figure 27 Menactra Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Menveo Market Forecast by Region, 2023-2033 (US$ million)
Figure 29 Menveo Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 31 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Meningococcal Vaccines Market Attractiveness Index by End-users
Figure 33 Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 34 Meningococcal Vaccines Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 35 Pediatric Market Forecast by Region, 2023-2033 (US$ million)
Figure 36 Pediatric Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Adult Market Forecast by Region, 2023-2033 (US$ million)
Figure 38 Adult Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Travelers Market Forecast by Region, 2023-2033 (US$ million)
Figure 40 Travelers Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Meningococcal Vaccines Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 42 Meningococcal Vaccines Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 43 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn)
Figure 44 North America Meningococcal Vaccines Market Attractiveness Index
Figure 45 North America Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 46 North America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 47 North America Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 48 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 49 North America Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 50 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 51 North America Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
Figure 52 North America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 53 North America Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 54 U.S. Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 55 Canada Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 56 Europe Meningococcal Vaccines Market Attractiveness Index
Figure 57 Europe Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 58 Europe Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 59 Europe Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 60 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 61 Europe Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 62 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 63 Europe Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
Figure 64 Europe Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 65 Europe Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 66 Germany Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 67 UK Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 68 France Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 69 Italy Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 70 Spain Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 71 Russia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 72 Rest of Europe Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 73 Asia Pacific Meningococcal Vaccines Market Attractiveness Index
Figure 74 Asia Pacific Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 75 Asia Pacific Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 76 Asia Pacific Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 78 Asia Pacific Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 79 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 80 Asia Pacific Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
Figure 81 Asia Pacific Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 82 Asia Pacific Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 83 Japan Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 84 China Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 85 India Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 86 Number of IMD Cases in Australia, 1991–2021
Figure 87 Proportion of Serogroups of Laboratory-Confirmed IMD, Australia, 2000 – 2021
Figure 88 Australia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 89 South Korea Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 90 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 91 Latin America Meningococcal Vaccines Market Attractiveness Index
Figure 92 Latin America Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 93 Latin America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 94 Latin America Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 95 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 96 Latin America Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 97 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 98 Latin America Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
Figure 99 Latin America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 100 Latin America Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 101 Brazil Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 102 Mexico Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 103 Rest of Latin America Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 104 MEA Meningococcal Vaccines Market Attractiveness Index
Figure 105 MEA Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 106 MEA Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 107 MEA Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 108 MEA Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 109 MEA Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 110 MEA Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 111 MEA Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
Figure 112 MEA Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 113 MEA Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 114 GCC Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 115 South Africa Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 116 Rest of MEA Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 117 Sanofi: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 118 Sanofi: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 119 Sanofi: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 120 Sanofi: Regional Market Share, 2021
Figure 121 Merck & Co. Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 122 Merck & Co. Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 123 Merck & Co. Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 124 Merck & Co. Inc.: Regional Market Share, 2021
Figure 125 GSK plc: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 126 GSK plc: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 127 GSK plc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 128 GSK plc: Regional Market Share, 2021
Figure 129 Pfizer Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 130 Pfizer Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 131 Pfizer Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 132 Pfizer Inc.: Regional Market Share, 2021
ページTOPに戻る
Summary
Report Details
The Meningococcal Vaccines Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increasing Prevalence of Meningitis Driving Market Growth
Increasing adoption of meningococcal vaccines and the growing prevalence of meningitis and other viral diseases in developed as well as developing regions is anticipated to drive market growth. Also, the growing investment in R&D and novel drug launches for the treatment of viral diseases is further boosting the market growth. The developed regions including the U.S., Japan, and Europe accounted for a large share in the market is due to the well-developed healthcare infrastructure and better healthcare awareness in developed countries compared to developing countries. Thus, the demand for advanced and more efficient drugs is high in these regions. Whereas the market in emerging economies such as China, India, and South Africa is growing at a high pace owing to government initiatives, growing respiratory health awareness, and increasing disposable income.
What Questions Should You Ask before Buying a Market Research Report?
• How is the meningococcal vaccines market evolving?
• What is driving and restraining the meningococcal vaccines market?
• How will each meningococcal vaccines submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each meningococcal vaccines submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading meningococcal vaccines markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the meningococcal vaccines projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
meningococcal vaccines projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the meningococcal vaccines market?
• Where is the meningococcal vaccines market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the meningococcal vaccines market today, and over the next 10 years:
• Our 214-page report provides 83 tables and 132 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the meningococcal vaccines market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Vaccine Type
• Conjugate
• Polysaccharide
• Others
Vaccine Brand
• Bexsero
• Menactra
• Menveo
• Others
End-users
• Pediatric
• Adult
• Travelers
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Meningococcal Vaccines Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• BIO-MED
• GSK plc
• Incepta Pharmaceuticals Ltd.
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi
• Serum Institute of India Pvt. Ltd.
• Walvax Biotechnology Co., Ltd.
• Zhi Fei Biological
Overall world revenue for Meningococcal Vaccines Market, 2023 to 2033 in terms of value the market will surpass US$3,443.4 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Meningococcal Vaccines Market, 2023 to 2033 report help you?
In summary, our 210+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Meningococcal Vaccines Market, 2023 to 2033 Market, with forecasts for Vaccine Type, Vaccine Brand, and End-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 21 key national markets – See forecasts for the Meningococcal Vaccines Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 9 of the major companies involved in the Meningococcal Vaccines Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Meningococcal Vaccines Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1. Report Overview
1.1 Objectives of the Study
1.2 Introduction to Meningococcal Vaccines Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increasing Prevalence of Meningitis
3.2.1.2 Increasing Initiatives by Government and Regulatory Authorities
3.2.1.3 Presence of Non-profit Organizations Providing Funds for Research Projects
3.2.1.4 Vaccine Trials Are Expected to be Commercialized During the Forecast Period
3.2.2 Market Restraining Factors
3.2.2.1 Low Production Rate and High Cost
3.2.2.2 High Costs of Drug Development Limits the Entry of New Players
3.2.2.3 Long Vaccine Manufacturing Timelines to Impede the Growth of the Vaccines Market
3.2.3 Market Opportunities
3.2.3.1 Increasing Inclusion in NIPs Unlocking New Windows of Opportunities
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Supplier: Moderate
3.4.2 Bargaining Power of Buyer: Moderate
3.4.3 Competitive Rivalry: High
3.4.4 Threat of New Entrants: low
3.4.5 Threat of Substitutes: Low
3.5 PEST Analysis
3.5.1 Political Factors Impacting Meningococcal Vaccines Market
3.5.2 Economic Factors Impacting Meningococcal Vaccines Market
3.5.3 Social Factors Impacting Meningococcal Vaccines Market
3.5.4 Technological Factors Impacting Meningococcal Vaccines Market
4 Meningococcal Vaccines Market Analysis by Vaccine Type
4.1 Key Findings
4.2 Vaccine Type Segment: Market Attractiveness Index
4.3 Meningococcal Vaccines Market Size Estimation and Forecast by Vaccine Type
4.4 Conjugate
4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Polysaccharide
4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Others
4.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
5 Meningococcal Vaccines Market Analysis by Vaccine Brand
5.1 Key Findings
5.2 Vaccine Brand Segment: Market Attractiveness Index
5.3 Meningococcal Vaccines Market Size Estimation and Forecast by Vaccine Brand
5.4 Bexsero
5.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Menactra
5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Menveo
5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Others
5.7.1 Market Forecast by Region, 2023-2033 (US$ Mn)
5.7.2 Market Share by Region, 2023 & 2033 (%)
6 Meningococcal Vaccines Market Analysis by End-users
6.1 Key Findings
6.2 End-users Segment: Market Attractiveness Index
6.3 Meningococcal Vaccines Market Size Estimation and Forecast by End-users
6.4 Pediatric
6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Adult
6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Travelers
6.6.1 Market Forecast by Region, 2023-2033 (US$ Mn)
6.6.2 Market Share by Region, 2023 & 2033 (%)
7 Meningococcal Vaccines Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Meningococcal Vaccines Market Analysis
8.1 Key Findings
8.2 North America Meningococcal Vaccines Market Attractiveness Index
8.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
8.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
8.5 Market Size Estimation and Forecast by Vaccine Type, 2023-2033 (US$ Mn)
8.6 Market Size Estimation and Forecast by Vaccine Brand, 2023-2033 (US$ Mn)
8.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
8.8 U.S. Meningococcal Vaccines Market Analysis
8.9 Canada Meningococcal Vaccines Market Analysis
9 Europe Meningococcal Vaccines Market Analysis
9.1 Key Findings
9.2 Europe Meningococcal Vaccines Market Attractiveness Index
9.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
9.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
9.5 Market Size Estimation and Forecast by Vaccine Type, 2023-2033 (US$ Mn)
9.6 Market Size Estimation and Forecast by Vaccine Brand, 2023-2033 (US$ Mn)
9.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
9.8 Germany Meningococcal Vaccines Market Analysis
9.9 UK Meningococcal Vaccines Market Analysis
9.10 France Meningococcal Vaccines Market Analysis
9.11 Italy Meningococcal Vaccines Market Analysis
9.12 Spain Meningococcal Vaccines Market Analysis
9.13 Russia Meningococcal Vaccines Market Analysis
9.14 Rest of Europe Meningococcal Vaccines Market Analysis
10 Asia Pacific Meningococcal Vaccines Market Analysis
10.1 Key Findings
10.2 Asia Pacific Meningococcal Vaccines Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
10.5 Market Size Estimation and Forecast by Vaccine Type, 2023-2033 (US$ Mn)
10.6 Market Size Estimation and Forecast by Vaccine Brand, 2023-2033 (US$ Mn)
10.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
10.8 Japan Meningococcal Vaccines Market Analysis
10.9 China Meningococcal Vaccines Market Analysis
10.10 India Meningococcal Vaccines Market Analysis
10.11 Australia Meningococcal Vaccines Market Analysis
10.12 South Korea Meningococcal Vaccines Market Analysis
10.13 Rest of Asia Pacific Meningococcal Vaccines Market Analysis
11 Latin America Meningococcal Vaccines Market Analysis
11.1 Key Findings
11.2 Latin America Meningococcal Vaccines Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
11.5 Market Size Estimation and Forecast by Vaccine Type, 2023-2033 (US$ Mn)
11.6 Market Size Estimation and Forecast by Vaccine Brand, 2023-2033 (US$ Mn)
11.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
11.8 Brazil Meningococcal Vaccines Market Analysis
11.9 Mexico Meningococcal Vaccines Market Analysis
11.10 Rest of Latin America Meningococcal Vaccines Market Analysis
12 MEA Meningococcal Vaccines Market Analysis
12.1 Key Findings
12.2 MEA Meningococcal Vaccines Market Attractiveness Index
12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
12.5 Market Size Estimation and Forecast by Vaccine Type, 2023-2033 (US$ Mn)
12.6 Market Size Estimation and Forecast by Vaccine Brand, 2023-2033 (US$ Mn)
12.7 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
12.8 GCC Meningococcal Vaccines Market Analysis
12.9 South Africa Meningococcal Vaccines Market Analysis
12.10 Rest of MEA Meningococcal Vaccines Market Analysis
13 Company Profiles
13.1 Pipeline Analysis
13.2 Sanofi
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2015-2021
13.2.3.2 R&D Expenses, 2015-2021
13.2.3.3 Gross Profit, 2015-2021
13.2.3.4 Regional Market Share, 2021
13.2.4 Product Benchmarking
13.2.5 Strategic Outlook
13.3 Merck & Co., Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2015-2021
13.3.3.2 R&D Expenses, 2015-2021
13.3.3.3 Gross Profit, 2015-2021
13.3.3.4 Regional Market Share, 2021
13.3.4 Product Benchmarking
13.4 GSK plc
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2015-2021
13.4.3.2 R&D Expenses, 2015-2021
13.4.3.3 Gross Profit, 2015-2021
13.4.3.4 Regional Market Share, 2021
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 Pfizer Inc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2015-2021
13.5.3.2 R&D Expenses, 2015-2021
13.5.3.3 Gross Profit, 2015-2021
13.5.3.4 Regional Market Share, 2021
13.5.4 Product Benchmarking
13.5.5 Strategic Outlook
13.6 Serum Institute of India Pvt. Ltd.
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Product Benchmarking
13.7 Zhi Fei Biological
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Product Benchmarking
13.8 Incepta Pharmaceuticals Ltd.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Product Benchmarking
13.9 Walvax Biotechnology Co., Ltd.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Product Benchmarking
13.10 BIO-MED
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
List of Tables
Table 1 Meningococcal Vaccines Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%): "L" Shaped Recovery
Table 6 Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 7 Conjugate Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 8 Polysaccharide Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 9 Others Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 10 Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 11 Bexsero Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 12 Menactra Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 13 Menveo Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 14 Others Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 15 Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 16 Pediatric Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 17 Adult Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 18 Travelers Segment Market Forecast by Region, 2022-2032 (US$ mn, AGR%, CAGR%)
Table 19 Meningococcal Vaccines Market Forecast by Region, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 20 North America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 21 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 22 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 23 North America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 24 U.S. Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 25 Canada Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 26 Europe Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 27 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 28 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 29 Europe Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 30 Germany Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 31 UK Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 32 France Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 33 Italy Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 34 Spain Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 35 Russia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 36 Rest of Europe Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 37 Overview of the Epidemiology and Prevention of IMD Across the Asia–Pacific Region
Table 38 Asia Pacific Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 39 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 40 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 41 Asia Pacific Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 42 Japan Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 43 China Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 44 India Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 45 Australia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 46 South Korea Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 47 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 48 Latin America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 49 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 50 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 51 Latin America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 52 Brazil Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 53 Mexico Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 54 Rest of Latin America Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 55 MEA Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 56 MEA Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 57 MEA Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 58 MEA Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 59 GCC Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 60 South Africa Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 61 Rest of MEA Meningococcal Vaccines Market Forecast, 2023-2033 (US$ mn, AGR%, CAGR%)
Table 62 Meningococcal Vaccine: Pipeline Analysis
Table 63 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 64 Sanofi: Product Benchmarking
Table 65 Sanofi: Strategic Outlook
Table 66 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 67 Merck & Co., Inc.: Product Benchmarking
Table 68 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 69 GSK plc: Product Benchmarking
Table 70 GSK plc: Strategic Outlook
Table 71 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 72 Pfizer Inc.: Product Benchmarking
Table 73 Pfizer Inc.: Strategic Outlook
Table 74 Serum Institute of India Pvt. Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 75 Serum Institute of India Pvt. Ltd.: Product Benchmarking
Table 76 Zhi Fei Biological: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 Zhi Fei Biological: Product Benchmarking
Table 78 Incepta Pharmaceuticals Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 Incepta Pharmaceuticals Ltd.: Product Benchmarking
Table 80 Walvwax Biotechnology Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 Walvax Biotechnology Co., Ltd.: Product Benchmarking
Table 82 BIO-MED: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 BIO-MED: Product Benchmarking
List of Figures
Figure 1 Meningococcal Vaccines Market Segmentation
Figure 2 Meningococcal Vaccines Market by Vaccine Type: Market Attractiveness Index
Figure 3 Meningococcal Vaccines Market by End-users: Market Attractiveness Index
Figure 4 Meningococcal Vaccines Market Attractiveness Index by Region
Figure 5 Meningococcal Vaccines Market: Market Dynamics
Figure 6 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 7 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 8 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 9 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 10 Meningococcal Vaccines Market: Porter’s Five Forces Analysis
Figure 11 Meningococcal Vaccines Market: PEST Analysis
Figure 12 Meningococcal Vaccines Market Attractiveness Index by Vaccine Type
Figure 13 Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 14 Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023, 2028, 2033 (%)
Figure 15 Conjugate Market Forecast by Region, 2023-2033 (US$ million)
Figure 16 Conjugate Market Share Forecast by Region, 2023 & 2033 (%)
Figure 17 Polysaccharide Market Forecast by Region, 2023-2033 (US$ million)
Figure 18 Polysaccharide Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 20 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Meningococcal Vaccines Market Attractiveness Index by Vaccine Type
Figure 22 Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 23 Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023, 2028, 2033 (%)
Figure 24 Bexsero Market Forecast by Region, 2023-2033 (US$ million)
Figure 25 Bexsero Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Menactra Market Forecast by Region, 2023-2033 (US$ million)
Figure 27 Menactra Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Menveo Market Forecast by Region, 2023-2033 (US$ million)
Figure 29 Menveo Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Others Market Forecast by Region, 2023-2033 (US$ million)
Figure 31 Others Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Meningococcal Vaccines Market Attractiveness Index by End-users
Figure 33 Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 34 Meningococcal Vaccines Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 35 Pediatric Market Forecast by Region, 2023-2033 (US$ million)
Figure 36 Pediatric Market Share Forecast by Region, 2023 & 2033 (%)
Figure 37 Adult Market Forecast by Region, 2023-2033 (US$ million)
Figure 38 Adult Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Travelers Market Forecast by Region, 2023-2033 (US$ million)
Figure 40 Travelers Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Meningococcal Vaccines Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 42 Meningococcal Vaccines Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 43 Meningococcal Vaccines Market by Region, 2023-2033 (US$ Mn)
Figure 44 North America Meningococcal Vaccines Market Attractiveness Index
Figure 45 North America Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 46 North America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 47 North America Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 48 North America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 49 North America Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 50 North America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 51 North America Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
Figure 52 North America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 53 North America Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 54 U.S. Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 55 Canada Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 56 Europe Meningococcal Vaccines Market Attractiveness Index
Figure 57 Europe Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 58 Europe Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 59 Europe Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 60 Europe Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 61 Europe Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 62 Europe Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 63 Europe Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
Figure 64 Europe Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 65 Europe Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 66 Germany Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 67 UK Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 68 France Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 69 Italy Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 70 Spain Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 71 Russia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 72 Rest of Europe Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 73 Asia Pacific Meningococcal Vaccines Market Attractiveness Index
Figure 74 Asia Pacific Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 75 Asia Pacific Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 76 Asia Pacific Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 77 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 78 Asia Pacific Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 79 Asia Pacific Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 80 Asia Pacific Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
Figure 81 Asia Pacific Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 82 Asia Pacific Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 83 Japan Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 84 China Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 85 India Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 86 Number of IMD Cases in Australia, 1991–2021
Figure 87 Proportion of Serogroups of Laboratory-Confirmed IMD, Australia, 2000 – 2021
Figure 88 Australia Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 89 South Korea Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 90 Rest of Asia Pacific Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 91 Latin America Meningococcal Vaccines Market Attractiveness Index
Figure 92 Latin America Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 93 Latin America Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 94 Latin America Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 95 Latin America Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 96 Latin America Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 97 Latin America Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 98 Latin America Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
Figure 99 Latin America Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 100 Latin America Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 101 Brazil Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 102 Mexico Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 103 Rest of Latin America Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 104 MEA Meningococcal Vaccines Market Attractiveness Index
Figure 105 MEA Meningococcal Vaccines Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 106 MEA Meningococcal Vaccines Market Forecast by Country, 2023-2033 (US$ million)
Figure 107 MEA Meningococcal Vaccines Market Share Forecast by Country, 2023 & 2033 (%)
Figure 108 MEA Meningococcal Vaccines Market Forecast by Vaccine Type, 2023-2033 (US$ million)
Figure 109 MEA Meningococcal Vaccines Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
Figure 110 MEA Meningococcal Vaccines Market Forecast by Vaccine Brand, 2023-2033 (US$ million)
Figure 111 MEA Meningococcal Vaccines Market Share Forecast by Vaccine Brand, 2023 & 2033 (%)
Figure 112 MEA Meningococcal Vaccines Market Forecast by End-users, 2023-2033 (US$ million)
Figure 113 MEA Meningococcal Vaccines Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 114 GCC Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 115 South Africa Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 116 Rest of MEA Meningococcal Vaccines Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 117 Sanofi: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 118 Sanofi: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 119 Sanofi: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 120 Sanofi: Regional Market Share, 2021
Figure 121 Merck & Co. Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 122 Merck & Co. Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 123 Merck & Co. Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 124 Merck & Co. Inc.: Regional Market Share, 2021
Figure 125 GSK plc: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 126 GSK plc: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 127 GSK plc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 128 GSK plc: Regional Market Share, 2021
Figure 129 Pfizer Inc.: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 130 Pfizer Inc.: R&D Expenses, 2015-2021 (US$ million, AGR%)
Figure 131 Pfizer Inc.: Gross Profit, 2015-2021 (US$ million, AGR%)
Figure 132 Pfizer Inc.: Regional Market Share, 2021
ページTOPに戻る
本レポートと同分野（抗感染性薬物）の最新刊レポート
Visiongain社の医薬・化学品分野での最新刊レポート
本レポートと同じKEY WORD（vaccine）の最新刊レポート
- 本レポートと同じKEY WORDの最新刊レポートはありません。
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
